Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Hepatitis C

Free Subscription 17.06.2019 2 BMC Gastroenterol 1 J Gen Virol 2 J Hepatol 3 J Viral Hepat 1 PLoS One 1 Transplant Proc

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

BMC Gastroenterol

1. SAKAMAKI A, Kamimura K, Fukui N, Watanabe H, et al
   A case report of psychiatric symptoms following direct-acting antiviral and ribavirin combination therapy for chronic hepatitis C in a patient with innate anxiety.
   BMC Gastroenterol. 2019;19:85.
   PubMed     Text format     Abstract available
   
   
2. LI Y, Wang X, Yu G, Sun H, et al
   The association of hepatitis c virus infection status with serum glucose levels.
   BMC Gastroenterol. 2019;19:86.
   PubMed     Text format     Abstract available
   
   

   
   J Gen Virol

3. OSAWA M, Uchida T, Imamura M, Teraoka Y, et al
   Efficacy of glecaprevir and pibrentasvir treatment for genotype 1b hepatitis C virus drug resistance-associated variants in humanized mice.
   J Gen Virol. 2019 Jun 14. doi: 10.1099/jgv.0.001268.
   PubMed     Text format     Abstract available
   
   

   
   J Hepatol

4. BORGIA SM, Dearden J, Yoshida EM, Shafran SD, et al
   Sofosbuvir/Velpatasvir for 12 Weeks in Hepatitis C Virus-Infected Patients with End-Stage Renal Disease Undergoing Dialysis.
   J Hepatol. 2019 Jun 10. pii: S0168-8278(19)30343.
   PubMed     Text format     Abstract available
   
   
5. SAPENA V, Rios J, Torres F, Marino Z, et al
   Reply to: "Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules - A response".
   J Hepatol. 2019 Jun 7. pii: S0168-8278(19)30280.
   PubMed     Text format    
   
   

   
   J Viral Hepat

6. DEGASPERI E, Galmozzi E, Facchetti F, Farina E, et al
   TLL1 Variants do not predict hepatocellular carcinoma development in hcv cirrhotic patients treated with direct-acting antivirals.
   J Viral Hepat. 2019 Jun 8. doi: 10.1111/jvh.13155.
   PubMed     Text format     Abstract available
   
   
7. LU M, Wu KH, Li J, Moorman AC, et al
   Adjuvant ribavirin and longer direct-acting antiviral treatment duration improve sustained virological response among hepatitis C patients at risk of treatment failure.
   J Viral Hepat. 2019 Jun 13. doi: 10.1111/jvh.13162.
   PubMed     Text format     Abstract available
   
   
8. RAGONNET-CRONIN M, Hostager R, Hedskog C, Osinusi A, et al
   HIV co-infection is associated with increased transmission risk in patients with chronic hepatitis C virus.
   J Viral Hepat. 2019 Jun 13. doi: 10.1111/jvh.13160.
   PubMed     Text format     Abstract available
   
   

   
   PLoS One

9. PAVICIC IVELJA M, Ivic I, Dolic K, Mestrovic A, et al
   Evaluation of cerebrovascular reactivity in chronic hepatitis C patients using transcranial color Doppler.
   PLoS One. 2019;14:e0218206.
   PubMed     Text format     Abstract available
   
   

   
   Transplant Proc

10. FAUST I, Weile J, Fujita B, Kandolf R, et al
    Heart Transplantation in Systemic Sclerosis: New Impulses for Conventional Scleroderma Transplantation Regimen and Scleroderma Diagnostic Monitoring: 2 Case Reports.
    Transplant Proc. 2019;51:865-870.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: